Acadian Asset Management LLC Harmony Biosciences Holdings, Inc. Transaction History

Acadian Asset Management LLC

  • $34.5 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$30.0 - $39.95 $144,570 - $192,519
4,819 New
4,819 $192,000
Q2 2022

Aug 09, 2022
SELL
$33.54 - $52.15 $21,566 - $33,532
-643 Reduced 19.1%
2,724 $133,000
Q1 2022

May 12, 2022
BUY
$33.14 - $51.13 $45,832 - $70,712
1,383 Added 69.71%
3,367 $163,000
Q4 2021

Feb 10, 2022
BUY
$34.09 - $43.91 $67,634 - $87,117
1,984 New
1,984 $84,000

Others Institutions Holding HRMY

# of Institutions
254
Shares Held
46.6M
Call Options Held
119K
Put Options Held
50K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email